Pregled bibliografske jedinice broj: 1239031
POSC222 Eureca - Exploring reimbursement models for medication adherence enhancing interventions in European countries: a survey protocol
POSC222 Eureca - Exploring reimbursement models for medication adherence enhancing interventions in European countries: a survey protocol // Value in health
Amsterdam, Netherlands, 2022. S151, 1 doi:10.1016/j.jval.2021.11.737 (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 1239031 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
POSC222 Eureca - Exploring reimbursement models
for medication adherence enhancing interventions
in European countries: a survey protocol
Autori
Agh, T ; Ortner Hadziabdic, M ; Garuoliene, K ; Fonseca, PB ; Menditto, E ; Kostalova, B ; Aarnio, EJ ; Kardas, P
Kolaboracija
ENABLE
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
Value in health
/ - , 2022
Skup
Virtual ISPOR Europe 2022 conference
Mjesto i datum
Amsterdam, Netherlands, 06.11.2022. - 09.11.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
reimbursement ; adherence
Sažetak
Current literature lacks detailed understanding of the reimbursement framework of medication adherence enhancing interventions (MAEIs). As part of the ENABLE COST Action (CA19132), the EUREcA (EUropen REimbursement strategies for interventions targeting medication Adherence) study aims to fill in this gap and provide an in- depth overview of reimbursed MAEIs currently available in European countries at national and regional levels.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Profili:
Maja Ortner Hadžiabdić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
